Stay updated on Emricasan in NASH Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Emricasan in NASH Fibrosis Clinical Trial page.

Latest updates to the Emricasan in NASH Fibrosis Clinical Trial page
- CheckyesterdayChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, signaling a minor update to the page’s underlying template or CMS. This change does not affect the study details, content, or user-facing functionality.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision label on the page updated from v3.6.4 to v3.6.5. This signifies a minor build/content update and does not change the study information presented.SummaryDifference0.0%

- Check36 days agoChange DetectedFooter revision label updated from v3.6.3 to v3.6.4, indicating a small update to the page's versioning. It does not modify any study data or displayed content.SummaryDifference0.0%

- Check51 days agoChange DetectedSteatotic Liver Disease has been added and Fatty Liver Disease removed from the page's keyword taxonomy, reflecting updated naming conventions for liver conditions and affecting how the study is indexed and discovered.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page now shows Revision: v3.6.3 instead of v3.6.2, signaling a small underlying update to the site version rather than a modification to study details.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a new revision in the page history.SummaryDifference0.0%

Stay in the know with updates to Emricasan in NASH Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emricasan in NASH Fibrosis Clinical Trial page.